TD Private Client Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.7K | Sell |
504
-178
| -26% | -$9.79K | ﹤0.01% | 941 |
|
|
2025
Q1 | $48.2K | Buy |
682
+46
| +7% | +$3.25K | ﹤0.01% | 819 |
|
|
2024
Q4 | $41.8K | Buy |
636
+126
| +25% | +$8.28K | ﹤0.01% | 856 |
|
|
2024
Q3 | $35.8K | Buy |
510
+186
| +57% | +$13.1K | ﹤0.01% | 888 |
|
|
2024
Q2 | $26.7K | Buy |
324
+75
| +30% | +$6.18K | ﹤0.01% | 907 |
|
|
2024
Q1 | $21.7K | Buy |
249
+108
| +77% | +$9.43K | ﹤0.01% | 939 |
|
|
2023
Q4 | $13.6K | Buy |
141
+24
| +21% | +$2.31K | ﹤0.01% | 1010 |
|
|
2023
Q3 | $10.4K | Buy |
117
+11
| +10% | +$973 | ﹤0.01% | 1026 |
|
|
2023
Q2 | $9.19K | Buy |
106
+26
| +33% | +$2.25K | ﹤0.01% | 1064 |
|
|
2023
Q1 | $7.78K | Buy |
80
+14
| +21% | +$1.36K | ﹤0.01% | 1064 |
|
|
2022
Q4 | $6.83K | Buy |
66
+10
| +18% | +$1.04K | ﹤0.01% | 1053 |
|
|
2022
Q3 | $4.75K | Hold |
56
| – | – | ﹤0.01% | 1063 |
|
|
2022
Q2 | $4.64K | Hold |
56
| – | – | ﹤0.01% | 1080 |
|
|
2022
Q1 | $4.32K | Sell |
56
-14
| -20% | -$1.08K | ﹤0.01% | 1109 |
|
|
2021
Q4 | $6.19K | Buy |
70
+30
| +75% | +$2.65K | ﹤0.01% | 942 |
|
|
2021
Q3 | $3.09K | Sell |
40
-8
| -17% | -$618 | ﹤0.01% | 996 |
|
|
2021
Q2 | $4.01K | Buy |
48
+11
| +30% | +$918 | ﹤0.01% | 977 |
|
|
2021
Q1 | $2.79K | Buy |
37
+15
| +68% | +$1.13K | ﹤0.01% | 980 |
|
|
2020
Q4 | $1.93K | Buy |
22
+4
| +22% | +$351 | ﹤0.01% | 961 |
|
|
2020
Q3 | $1.37K | Buy |
18
+10
| +125% | +$761 | ﹤0.01% | 941 |
|
|
2020
Q2 | $987 | Sell |
8
-27
| -77% | -$3.33K | ﹤0.01% | 960 |
|
|
2020
Q1 | $2.96K | Hold |
35
| – | – | ﹤0.01% | 849 |
|
|
2019
Q4 | $2.96K | Buy |
+35
| New | +$2.96K | ﹤0.01% | 871 |
|